Pieris Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, discovers and develops anticalin-based drugs.
Pieris Pharmaceuticals stock last closed at $11.68, down 0.26% from the previous day, and has decreased 80.38% in one year. It has underperformed other stocks in the Biotechnology industry by 0.59 percentage points. Pieris Pharmaceuticals stock is currently +7.27% from its 52-week low of $10.89, and -85.54% from its 52-week high of $80.80.
There are currently 1.24M PIRS shares outstanding. The market cap of PIRS is $14.44M. In the last 24 hours, 47,621 PIRS shares were traded.
How to Buy Pieris Pharmaceuticals Stock
Not sure how to invest in Pieris Pharmaceuticals stock? Here's how.
Figure out where to buy Pieris Pharmaceuticals stock: You need to pick an online brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you choose where to buy Pieris Pharmaceuticals stock.
Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
Deposit money your investment account: Select your payment method and add your info.
Analyze Pieris Pharmaceuticals stock: The Pieris Pharmaceuticals ticker symbol is PIRS. Is Pieris Pharmaceuticals stock a good investment? Should you buy shares of PIRS? How do PIRS's underlying business fundamentals look? Do top analysts think Pieris Pharmaceuticals is a good buy? Why has PIRS's stock price moved recently? (Hint: Our stock market analysis tools can help you understand if PIRS is a good stock to buy).
Make your PIRS purchase: Decide if you will purchase PIRS shares at the current market price or use a limit order to purchase PIRS shares at a particular price.
Get the latest scoop on your investment in PIRS: Create a watchlist to monitor your investment in Pieris Pharmaceuticals shares.
Step 1: Figure out where to buy Pieris Pharmaceuticals stock
You will need a brokerage account in order to access the NASDAQ market and buy PIRS shares.
A brokerage account is an investment account that allows you to buy and sell a variety of investments, including stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best brokerage. Here's why:
Invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
Access to global financial markets: From Technology to Industrials, New York to Shanghai — you can fill your portfolio with stocks from the world's leading exchanges.
Social investing: eToro has a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by opening an account with eToro now.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open your brokerage account
Now that you've chosen the best brokerage, the next step is to fill out some personal information so you can buy PIRS today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Pieris Pharmaceuticals stock
Once you have selected the best place to buy Pieris Pharmaceuticals stock, it's crucial to analyze their stock before you invest, so you truly understand the risk and opportunity.
Pieris Pharmaceuticals Numbers
PIRS Price
$11.68
1w %
-2.1%
1y %
-80.38%
5y %
-95.1%
P/E
-0.54x
P/B
0.54x
P/S
0.31x
PEG
N/A
Revenue
$42.81M
Earnings
-$24.54M
Fore. Rev. Growth
-30.56%
Fore. Earn. Growth
N/A
Market Cap
$14.44M
Next Earnings
Jun 20, 2024
Next Dividend
N/A
PIRS Overview
WallStreetZen was designed to help part-time investors perform better fundamental analysis in less time.
Last year, PIRS revenue was $42.81M. Over the last five year, PIRS's revenue has grown by 8.03% per year. This was slower than the Biotechnology industry average of 28.49%.
No, Pieris Pharmaceuticals doesn't provide an income stream by paying out dividends.
What do other investors have to say about PIRS?
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Make your PIRS purchase
There are two primary order types:
Market order: A market order is an order to buy or sell a stock at the best possible price. Market orders are mostly fine for most investors.
Limit order: A limit order is an order to buy or sell a security at a specific price (or better). If you want to be sure you're buying or selling at an exact price, use a limit order.
Hit the Open button and eToro will place your order.
If you want more help with buying stocks on eToro, click the how to video below:
How much does it cost to buy one Pieris Pharmaceuticals share?
As of May 1, 2024, it costs $11.68 to buy one share of Pieris Pharmaceuticals stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $5, you can buy 0.428 shares of PIRS.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.